197 related articles for article (PubMed ID: 10644484)
1. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of Clostridium difficile toxins on hepatocytes.
Mazuski JE; Panesar N; Tolman K; Longo WE
J Surg Res; 1998 Oct; 79(2):170-8. PubMed ID: 9758734
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile toxins influence hepatocyte protein synthesis through the interleukin 1 receptor.
Mazuski JE; Grossmann EM; Norman JG; Denham W; Panesar N; Shapiro MJ; Durham RL; Kaminski DL; Longo WE
Arch Surg; 2000 Oct; 135(10):1206-11. PubMed ID: 11030883
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of Clostridium difficile toxin B: role of external medium and cytoskeletal organization in intoxicated cells.
Ciesielski-Treska J; Ulrich G; Rihn B; Aunis D
Eur J Cell Biol; 1989 Apr; 48(2):191-202. PubMed ID: 2545447
[TBL] [Abstract][Full Text] [Related]
6. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.
Dreikhausen U; Varga G; Hofmann F; Barth H; Aktories K; Resch K; Szamel M
Eur J Immunol; 2001 May; 31(5):1610-9. PubMed ID: 11465119
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of cellular proteins in response to treatment with Clostridium difficile toxin B and Clostridium sordellii toxin L.
Ciesielski-Treska J; Ulrich G; Baldacini O; Monteil H; Aunis D
Eur J Cell Biol; 1991 Oct; 56(1):68-78. PubMed ID: 1724754
[TBL] [Abstract][Full Text] [Related]
8. Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity.
Duncan PI; Fotopoulos G; Pasche E; Porta N; Masserey Elmelegy I; Sanchez-Garcia JL; Bergonzelli GE; Corthésy-Theulaz I
FEMS Microbiol Lett; 2009 Jun; 295(2):218-25. PubMed ID: 19416358
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile toxin A stimulates enzyme secretion from isolated rat pancreatic acini.
Małecka-Panas E; Triadafilopoulos G; Tsukamoto H; Howitt G; Pothoulakis C; LaMont T
Mater Med Pol; 1993; 25(3-4):127-31. PubMed ID: 7520960
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
11. Comparison of wild type with recombinant Clostridium difficile toxin A.
Gerhard R; Burger S; Tatge H; Genth H; Just I; Hofmann F
Microb Pathog; 2005; 38(2-3):77-83. PubMed ID: 15748809
[TBL] [Abstract][Full Text] [Related]
12. Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.
Canny G; Drudy D; Macmathuna P; O'farrelly C; Baird AW
Life Sci; 2006 Jan; 78(9):920-5. PubMed ID: 16185718
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand.
Kim H; Rhee SH; Pothoulakis C; Lamont JT
Gastroenterology; 2007 Sep; 133(3):875-86. PubMed ID: 17854595
[TBL] [Abstract][Full Text] [Related]
14. IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta.
Gómez J; García A; R-Borlado L; Bonay P; Martínez-A C; Silva A; Fresno M; Carrera AC; Eicher-Streiber C; Rebollo A
J Immunol; 1997 Feb; 158(4):1516-22. PubMed ID: 9029085
[TBL] [Abstract][Full Text] [Related]
15. Toxin B of Clostridium difficile activates human VIP submucosal neurons, in part via an IL-1beta-dependent pathway.
Neunlist M; Barouk J; Michel K; Just I; Oreshkova T; Schemann M; Galmiche JP
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1049-55. PubMed ID: 12801886
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
[TBL] [Abstract][Full Text] [Related]
19. Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
Wang S; Rustandi RR; Lancaster C; Hong LG; Thiriot DS; Xie J; Secore S; Kristopeit A; Wang SC; Heinrichs JH
Vaccine; 2016 Mar; 34(10):1319-23. PubMed ID: 26614590
[TBL] [Abstract][Full Text] [Related]
20. Monocytes are highly sensitive to clostridium difficile toxin A-induced apoptotic and nonapoptotic cell death.
Solomon K; Webb J; Ali N; Robins RA; Mahida YR
Infect Immun; 2005 Mar; 73(3):1625-34. PubMed ID: 15731062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
